Literature DB >> 17684373

Epidemiology and comorbidity of erysipelas in primary care.

Stefaan Bartholomeeusen1, Jan Vandenbroucke, Carla Truyers, Frank Buntinx.   

Abstract

BACKGROUND/AIMS: Most studies on the epidemiology of erysipelas are done in hospitals, resulting in patient selection. The aim of this study is to determine epidemiological characteristics and comorbidity of erysipelas based on primary care data.
METHODS: Incidence rate study and nested case-control study. A database containing data from 52 general practices in Flanders, Belgium, with morbidity data on 160,000 different patients in the period 1994-2004. Excess comorbidity was determined in patients with erysipelas in 2004.
RESULTS: In the period 1994-2004, the age-standardized incidence of erysipelas increased significantly from 1.88 (95% confidence interval, CI, 1.62-2.13) per 1,000 patients to 2.49 (95% CI 2.24-2.74). Of patients with erysipelas, 16% had one or more recurrences. Local factors such as dermatophytosis, chronic ulcer of the skin, varicose veins of the leg and phlebitis and general disorders such as obesity, non-insulin-dependent diabetes and heart failure increased the risk of erysipelas.
CONCLUSION: The incidence of erysipelas increased from 1994 to 2004. More attention should be paid to local factors such as dermatophytosis to prevent erysipelas. Copyright (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 17684373     DOI: 10.1159/000104262

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  15 in total

1.  Recurrent cellulitis: risk factors, etiology, pathogenesis and treatment.

Authors:  Maciej Piotr Chlebicki; Choon Chiat Oh
Journal:  Curr Infect Dis Rep       Date:  2014-09       Impact factor: 3.725

2.  Recurrent cellulitis with benzathine penicillin prophylaxis is associated with diabetes and psoriasis.

Authors:  M Karppelin; T Siljander; H Huhtala; A Aromaa; J Vuopio; K Hannula-Jouppi; J Kere; J Syrjänen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09-25       Impact factor: 3.267

3.  Bacterial cultures, rapid strep test, and antibiotic treatment in infected hard-to-heal ulcers in primary care.

Authors:  Rut F Oien; Nina Akesson
Journal:  Scand J Prim Health Care       Date:  2012-10-10       Impact factor: 2.581

Review 4.  Obesity: impact of infections and response to vaccines.

Authors:  C Tagliabue; N Principi; C Giavoli; S Esposito
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-12-30       Impact factor: 3.267

5.  How obesity impacts outcomes of infectious diseases.

Authors:  A Atamna; A Elis; E Gilady; L Gitter-Azulay; J Bishara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-18       Impact factor: 3.267

Review 6.  Obesity and infectious diseases: pathophysiology and epidemiology of a double pandemic condition.

Authors:  Gabriella Pugliese; Alessia Liccardi; Chiara Graziadio; Luigi Barrea; Giovanna Muscogiuri; Annamaria Colao
Journal:  Int J Obes (Lond)       Date:  2022-01-21       Impact factor: 5.095

7.  Risk factors associated with local complications of erysipelas: a retrospective study of 152 cases.

Authors:  Hicham Titou; Christelle Ebongo; Elarbi Bouati; Mohammed Boui
Journal:  Pan Afr Med J       Date:  2017-02-05

8.  Diet-induced obesity promotes infection by impairment of the innate antimicrobial defense function of dermal adipocyte progenitors.

Authors:  Ling-Juan Zhang; Christian F Guerrero-Juarez; Stella X Chen; Xiaowei Zhang; Meimei Yin; Fengwu Li; Shuai Wu; Joyce Chen; Min Li; Yingzi Liu; Shang I B Jiang; Tissa Hata; Maksim V Plikus; Richard L Gallo
Journal:  Sci Transl Med       Date:  2021-01-20       Impact factor: 17.956

9.  Recurrent erysipelas--risk factors and clinical presentation.

Authors:  Malin Inghammar; Magnus Rasmussen; Adam Linder
Journal:  BMC Infect Dis       Date:  2014-05-18       Impact factor: 3.090

10.  [Evaluation of general practitioners' knowledge about diagnostic and therapeuthic management of erysipelas in the city of Marrakech].

Authors:  Fatima Ihbibane; Ntini Lebi Arsène; Latifa Adarmouch; Mohamed Amine; Noura Tassi
Journal:  Pan Afr Med J       Date:  2018-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.